25% off all training courses Offer ends May 29, 2026
View HIPAA Courses
25% off all training courses
View HIPAA Courses
Offer ends May 29, 2026

The HIPAA Journal is the leading provider of HIPAA training, news, regulatory updates, and independent compliance advice.

HHS-OIG Settles Alleged EMTALA Violations with Tennessee and Missouri Health Systems

Two investigations by the Department of Health and Human Services Office of Inspector General (HHS-OIG) of potential violations of the Emergency Medical Treatment and Labor Act (EMTALA) have been settled with penalties of $97,500 and $258,464 to resolve the alleged EMTALA violations.

Under EMTALA, hospitals that accept Medicare payments are required to provide a medical screening examination (MSE) appropriate for the patient’s condition to any patient presenting at the hospital, regardless of their legal status, citizenship, or ability to pay. The patient must be provided with stabilizing treatment, except with informed consent, and the patient may not be transferred without stabilizing treatment unless the patient’s condition requires a transfer to a hospital that is better equipped to administer the stabilizing treatment.

The first case concerned a patient who presented at Memorial Health Care System in Chattanooga, Tennessee, in December 2021. According to HHS-OIG, a known diabetic patient presented at Memorial’s Emergency Room seeking treatment; however, had a verbal altercation with a member of staff after around 10 minutes and was escorted off the premises by law enforcement less than 10 minutes later, without having been provided with an MSE. HHS-OIG determined that this constituted an EMTALA violation and agreed to a $97,500 settlement in November 2024 to resolve the alleged violation.

The second case related to a pregnant patient who presented at the labor and delivery unit at Freeman Health System – Freeman West (Freeman) in Joplin, Missouri, in August 2022. The patient was seeking care for serious complications with her pregnancy, including bleeding, leaking amniotic fluid, and abdominal pressure and cramping. The patient had a history of miscarriage and had recently been diagnosed with deep vein thrombosis.

HHS OIG Exclusions List
What You Need To Know

Get The 6 Essentials Checklist For Compliance Officers

A link to your download will be sent to your email address

Your Privacy Respected

HIPAA Journal Privacy Policy

An MSE was provided, and the patient was diagnosed with preterm premature rupture of membranes at 17 weeks and 5 days of gestation. The patient was advised of the treatment options, which were continued observance or induced labor. The patient was informed that if labor was induced, the fetus would not be viable; however, there was also an extremely low chance that the patient would be able to continue to carry the fetus to a gestational age where survival was likely and that failing to opt for inducted labor would place the patient at risk of serious complications including maternal thrombosis, infection, sepsis, severe blood loss, hysterotomy, hysterectomy, and death.

The patient chose to have labor induced as the stabilizing treatment; however, the hospital offered to hold the patient to observe the deterioration of the patient’s condition before performing the stabilizing treatment. That decision resulted in the patient leaving the facility to visit another hospital due to the risks of delaying treatment. That treatment was not received at the next hospital she visited and she returned to Freeman the following day. Freeman again offered to monitor the patient to some point of deterioration, at which point labor would be induced; however, due to fear of the risks of delayed treatment, the patient left Freeman to pursue treatment elsewhere and was discharged home. HHS-OIG determined that the failure to provide stabilizing treatment constituted an EMTALA violation. The case was settled with Freeman in December 2024 and a $258,464 penalty was paid to resolve the alleged violation.

Author: Steve Alder is the editor-in-chief of The HIPAA Journal. Steve is responsible for editorial policy regarding the topics covered in The HIPAA Journal. He is a specialist on healthcare industry legal and regulatory affairs, and has 10 years of experience writing about HIPAA and other related legal topics. Steve has developed a deep understanding of regulatory issues surrounding the use of information technology in the healthcare industry and has written hundreds of articles on HIPAA-related topics. Steve shapes the editorial policy of The HIPAA Journal, ensuring its comprehensive coverage of critical topics. Steve Alder is considered an authority in the healthcare industry on HIPAA. The HIPAA Journal has evolved into the leading independent authority on HIPAA under Steve’s editorial leadership. Steve manages a team of writers and is responsible for the factual and legal accuracy of all content published on The HIPAA Journal. Steve holds a Bachelor’s of Science degree from the University of Liverpool. You can connect with Steve via LinkedIn or email via stevealder(at)hipaajournal.com

x

Is Your Organization HIPAA Compliant?

Find Out With Our Free HIPAA Compliance Checklist

Get Free Checklist